X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1416) 1416
Book Review (373) 373
Publication (60) 60
Book Chapter (8) 8
Conference Proceeding (5) 5
Newsletter (5) 5
Magazine Article (4) 4
Dissertation (3) 3
Trade Publication Article (2) 2
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
rivastigmine (1306) 1306
index medicus (1175) 1175
humans (1145) 1145
cholinesterase inhibitors - therapeutic use (778) 778
alzheimer disease - drug therapy (711) 711
aged (607) 607
male (598) 598
alzheimer's disease (550) 550
female (548) 548
donepezil (523) 523
dementia (498) 498
phenylcarbamates - therapeutic use (410) 410
alzheimers-disease (373) 373
pharmacology & pharmacy (360) 360
piperidines - therapeutic use (338) 338
indans - therapeutic use (337) 337
aged, 80 and over (333) 333
treatment outcome (333) 333
clinical neurology (323) 323
psychiatry (308) 308
double-blind (301) 301
middle aged (276) 276
galantamine (266) 266
efficacy (252) 252
geriatrics & gerontology (239) 239
phenylcarbamates (238) 238
cholinesterase inhibitors (233) 233
neurosciences (225) 225
galantamine - therapeutic use (219) 219
neuroprotective agents - therapeutic use (207) 207
cholinesterase inhibitors - adverse effects (206) 206
carbamates - therapeutic use (204) 204
nootropic agents - therapeutic use (188) 188
drug therapy (176) 176
neuropsychological tests (171) 171
cholinesterase-inhibitors (168) 168
animals (167) 167
dementia - drug therapy (164) 164
placebo-controlled trial (157) 157
cholinesterase inhibitors - pharmacology (155) 155
memantine - therapeutic use (142) 142
memantine (140) 140
alzheimer disease - psychology (134) 134
alzheimers disease (133) 133
cholinesterase inhibitors - administration & dosage (130) 130
double-blind method (130) 130
safety (129) 129
cognition disorders - drug therapy (121) 121
phenylcarbamates - adverse effects (120) 120
acetylcholinesterase (118) 118
medicine, general & internal (117) 117
cognition - drug effects (115) 115
activities of daily living (111) 111
gerontology (110) 110
severity of illness index (110) 110
randomized controlled trials as topic (108) 108
acetylcholinesterase inhibitors (102) 102
dose-response relationship, drug (99) 99
diagnosis (98) 98
phenylcarbamates - administration & dosage (97) 97
time factors (97) 97
brain (90) 90
indans - adverse effects (87) 87
piperidines - adverse effects (87) 87
cognition (86) 86
care and treatment (84) 84
alzheimer disease - physiopathology (83) 83
analysis (83) 83
moderate (82) 82
cholinesterase inhibitor (81) 81
parkinson disease - drug therapy (79) 79
lewy body disease - drug therapy (78) 78
memory (78) 78
prospective studies (77) 77
alzheimer disease - diagnosis (76) 76
cognitive impairment (76) 76
rats (76) 76
butyrylcholinesterase (74) 74
cognition disorders - etiology (74) 74
research (74) 74
adult (73) 73
disease progression (73) 73
retrospective studies (73) 73
dosage and administration (72) 72
neurology (72) 72
parkinson's disease (72) 72
tacrine (72) 72
clinical trials as topic (71) 71
transdermal patch (69) 69
antipsychotic agents - therapeutic use (68) 68
parkinson disease - complications (68) 68
risk factors (68) 68
lewy bodies (67) 67
rivastigmine - therapeutic use (67) 67
vascular dementia (67) 67
alzheimer disease - complications (66) 66
follow-up studies (66) 66
psychiatric status rating scales (66) 66
therapy (66) 66
clinical trials (64) 64
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1318) 1318
German (26) 26
Spanish (21) 21
Dutch (18) 18
French (18) 18
Russian (14) 14
Japanese (9) 9
Portuguese (4) 4
Danish (2) 2
Norwegian (2) 2
Polish (2) 2
Finnish (1) 1
Italian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Internal Medicine, ISSN 0003-4819, 03/2008, Volume 148, Issue 5, pp. 370 - 378
Journal Article
JAMA - Journal of the American Medical Association, ISSN 0098-7484, 01/2018, Volume 319, Issue 2, pp. 130 - 142
IMPORTANCE New therapeutic approaches for Alzheimer disease (AD) are needed. OBJECTIVE To assess whether idalopirdine, a selective 5-hydroxytryptamine-6... 
DONEPEZIL | 5-HT6 RECEPTOR ANTAGONIST | MODERATE | MEDICINE, GENERAL & INTERNAL | DOUBLE-BLIND | SEROTONIN | SB-742457 | RATING-SCALE | VALIDITY | Serotonin Antagonists - administration & dosage | Benzylamines - adverse effects | Humans | Middle Aged | Male | Indans - therapeutic use | Benzylamines - administration & dosage | Indoles - administration & dosage | Dose-Response Relationship, Drug | Serotonin Antagonists - adverse effects | Treatment Failure | Aged, 80 and over | Female | Drug Therapy, Combination | Accidental Falls | Alzheimer Disease - psychology | Double-Blind Method | Alzheimer Disease - drug therapy | Serotonin Antagonists - therapeutic use | Cognition - drug effects | Indoles - adverse effects | Galantamine - therapeutic use | Piperidines - therapeutic use | Cholinesterase Inhibitors - adverse effects | Indoles - therapeutic use | Aged | Rivastigmine - therapeutic use | Cholinesterase Inhibitors - therapeutic use | Benzylamines - therapeutic use | Treatment outcome | Care and treatment | Safety and security measures | Analysis | Clinical trials | Dosage and administration | Cholinesterase inhibitors | Alzheimer's disease | Drugs | Medical research | Activities of daily living | Galantamine | Neurodegenerative diseases | Serotonin | Medical treatment | Cognitive ability | Medical services | Cognition | Patients | Cholinesterase | Randomization | Safety engineering | Donepezil | Alzheimers disease | Index Medicus | Abridged Index Medicus | Original Investigation | Research
Journal Article
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2015, Volume 14, Issue 12, pp. 1171 - 1181
Journal Article
International Clinical Psychopharmacology, ISSN 0268-1315, 2014, Volume 29, Issue 4, pp. 216 - 223
Journal Article
Psychopharmacology, ISSN 0033-3158, 4/2016, Volume 233, Issue 7, pp. 1235 - 1243
Journal Article
Journal Article
Neurology, ISSN 0028-3878, 04/2007, Volume 68, Issue 17, pp. 1356 - 1363
Objective: To assess the efficacy and tolerability of quetiapine for agitation or psychosis in patients with dementia and parkinsonism. Methods: Multicenter... 
RIVASTIGMINE | CLOZAPINE | DIAGNOSIS | PLACEBO | CLINICAL-TRIAL | ALZHEIMERS-DISEASE | LEWY BODY | BEHAVIORAL DISTURBANCES | RISPERIDONE | SYMPTOMS | CLINICAL NEUROLOGY | Alzheimer Disease - complications | Antipsychotic Agents - adverse effects | Humans | Lewy Body Disease - complications | Male | Lewy Body Disease - psychology | Indans - therapeutic use | Psychomotor Agitation - drug therapy | Patient Selection | Activities of Daily Living | Antiparkinson Agents - therapeutic use | Psychomotor Agitation - etiology | Dibenzothiazepines - therapeutic use | Antipsychotic Agents - therapeutic use | Dibenzothiazepines - adverse effects | Treatment Failure | Aged, 80 and over | Female | Indans - administration & dosage | Drug Therapy, Combination | Severity of Illness Index | Parkinson Disease - complications | Piperidines - administration & dosage | Double-Blind Method | Dementia - drug therapy | Placebo Effect | Quetiapine Fumarate | Alzheimer Disease - drug therapy | Parkinson Disease - psychology | Dibenzothiazepines - administration & dosage | Antipsychotic Agents - administration & dosage | Neuropsychological Tests | Dementia - etiology | Confounding Factors (Epidemiology) | Cholinesterase Inhibitors - administration & dosage | Piperidines - therapeutic use | Aged | Antiparkinson Agents - administration & dosage | Psychotic Disorders - drug therapy | Cholinesterase Inhibitors - therapeutic use | Research Design | Psychotic Disorders - etiology | Index Medicus | Abridged Index Medicus
Journal Article